IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BCCG

Balance Sheet

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Cash & Equivalents--------------------0.000.00
Total Current Assets0.03----0.000.000.000.250.010.000.000.000.00
Total Assets0.120.090.090.090.090.090.340.100.090.090.090.09
Total Liabilities1.743.141.801.390.870.610.320.300.210.170.070.02
Retained Earnings(31.81)(30.91)(26.09)(22.39)(12.22)(8.26)(3.16)(1.78)(1.70)(1.65)(1.56)(1.50)
Total Stockholder Equity(1.62)(3.05)(1.71)(1.30)(0.78)(0.52)0.02(0.20)(0.12)(0.08)0.020.07
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Net Interest Income(0.17)(0.26)(0.24)(0.25)(0.16)0.02(0.09)----------
Net Income(0.90)(4.81)(3.71)(10.17)(3.96)(4.19)(1.38)(0.08)(0.04)(0.06)(0.06)(0.01)
Basic EPS(0.01)--(0.04)(0.11)(0.05)(0.05)(0.02)0.000.00-0.000.000.00
Diluted EPS(0.01)--(0.04)(0.11)(0.05)(0.05)(0.02)0.000.00-0.000.000.00
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Operating Cash Flow(718.03)(350.00)(100.28)(484.76)(370.36)(85.36)(539.27)(25.12)(3.60)(6.16)(2.75)(254.93)
Investing Cash Flow--------------------(4.00)--
Financing Cash Flow750.00350.00100.00485.00370.0085.00530.0035.001.007.502.20255.13
← Scroll for more columns →